Serum asprosin level in different subtypes of polycystic ovary syndrome: a cross-sectional study

SUMMARY OBJECTIVE: Polycystic ovary syndrome can be divided into different subtypes, including insulin resistance and hyperandrogenism. The aim of this study was to investigate the relationship between serum asprosin levels and polycystic ovary syndrome subtypes. METHODS: A total of 93 women with polycystic ovary syndrome and 77 healthy women as controls were selected for this study. The clinical and laboratory data were compared between the Polycystic ovary syndrome group and the control group. The Polycystic ovary syndrome group was further divided into subgroups: (1) women with or without hyperandrogenism (polycystic ovary syndrome hyperandrogenism and Polycystic ovary syndrome none-hyperandrogenism, respectively) and (2) women with or without insulin resistance (polycystic ovary syndrome insulin resistance and Polycystic ovary syndrome none-insulin resistance, respectively). Serum asprosin was measured by using enenzyme-linked immunosorbent assay. RESULTS: Serum asprosin levels showed no significant difference between the polycystic ovary syndrome and control groups. However, it was significantly lower in the Polycystic ovary syndrome HA and insulin resistance groups compared with the respective Polycystic ovary syndrome none-hyperandrogenism and none-insulin resistance groups (p<0.05). In the Polycystic ovary syndrome group, serum asprosin was negatively correlated with body mass index, luteinizing hormone, testosterone, basal antral follicles, fasting insulin, homeostatic model assessment of insulin resistance, and triglycerides. After adjusting for body mass index, the correlations were not significant, and asprosin was only positively correlated with prolactin (prolactin; r=0.426, p<0.001). CONCLUSION: Our study shows that women with polycystic ovary syndrome hyperandrogenism or insulin resistance exhibit significantly lower serum asprosin levels compared with controls, and the lower asprosin level directly correlated with prolactin level.

Saved in:
Bibliographic Details
Main Authors: Jiang,Yonghui, Liu,Yue, Yu,Zhiheng, Yang,Ping, Zhao,Shigang
Format: Digital revista
Language:English
Published: Associação Médica Brasileira 2021
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021000500590
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0104-42302021000500590
record_format ojs
spelling oai:scielo:S0104-423020210005005902021-09-03Serum asprosin level in different subtypes of polycystic ovary syndrome: a cross-sectional studyJiang,YonghuiLiu,YueYu,ZhihengYang,PingZhao,Shigang Hyperandrogenism Insulin resistance Asprosin protein SUMMARY OBJECTIVE: Polycystic ovary syndrome can be divided into different subtypes, including insulin resistance and hyperandrogenism. The aim of this study was to investigate the relationship between serum asprosin levels and polycystic ovary syndrome subtypes. METHODS: A total of 93 women with polycystic ovary syndrome and 77 healthy women as controls were selected for this study. The clinical and laboratory data were compared between the Polycystic ovary syndrome group and the control group. The Polycystic ovary syndrome group was further divided into subgroups: (1) women with or without hyperandrogenism (polycystic ovary syndrome hyperandrogenism and Polycystic ovary syndrome none-hyperandrogenism, respectively) and (2) women with or without insulin resistance (polycystic ovary syndrome insulin resistance and Polycystic ovary syndrome none-insulin resistance, respectively). Serum asprosin was measured by using enenzyme-linked immunosorbent assay. RESULTS: Serum asprosin levels showed no significant difference between the polycystic ovary syndrome and control groups. However, it was significantly lower in the Polycystic ovary syndrome HA and insulin resistance groups compared with the respective Polycystic ovary syndrome none-hyperandrogenism and none-insulin resistance groups (p<0.05). In the Polycystic ovary syndrome group, serum asprosin was negatively correlated with body mass index, luteinizing hormone, testosterone, basal antral follicles, fasting insulin, homeostatic model assessment of insulin resistance, and triglycerides. After adjusting for body mass index, the correlations were not significant, and asprosin was only positively correlated with prolactin (prolactin; r=0.426, p<0.001). CONCLUSION: Our study shows that women with polycystic ovary syndrome hyperandrogenism or insulin resistance exhibit significantly lower serum asprosin levels compared with controls, and the lower asprosin level directly correlated with prolactin level.info:eu-repo/semantics/openAccessAssociação Médica BrasileiraRevista da Associação Médica Brasileira v.67 n.4 20212021-04-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021000500590en10.1590/1806-9282.20201147
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Jiang,Yonghui
Liu,Yue
Yu,Zhiheng
Yang,Ping
Zhao,Shigang
spellingShingle Jiang,Yonghui
Liu,Yue
Yu,Zhiheng
Yang,Ping
Zhao,Shigang
Serum asprosin level in different subtypes of polycystic ovary syndrome: a cross-sectional study
author_facet Jiang,Yonghui
Liu,Yue
Yu,Zhiheng
Yang,Ping
Zhao,Shigang
author_sort Jiang,Yonghui
title Serum asprosin level in different subtypes of polycystic ovary syndrome: a cross-sectional study
title_short Serum asprosin level in different subtypes of polycystic ovary syndrome: a cross-sectional study
title_full Serum asprosin level in different subtypes of polycystic ovary syndrome: a cross-sectional study
title_fullStr Serum asprosin level in different subtypes of polycystic ovary syndrome: a cross-sectional study
title_full_unstemmed Serum asprosin level in different subtypes of polycystic ovary syndrome: a cross-sectional study
title_sort serum asprosin level in different subtypes of polycystic ovary syndrome: a cross-sectional study
description SUMMARY OBJECTIVE: Polycystic ovary syndrome can be divided into different subtypes, including insulin resistance and hyperandrogenism. The aim of this study was to investigate the relationship between serum asprosin levels and polycystic ovary syndrome subtypes. METHODS: A total of 93 women with polycystic ovary syndrome and 77 healthy women as controls were selected for this study. The clinical and laboratory data were compared between the Polycystic ovary syndrome group and the control group. The Polycystic ovary syndrome group was further divided into subgroups: (1) women with or without hyperandrogenism (polycystic ovary syndrome hyperandrogenism and Polycystic ovary syndrome none-hyperandrogenism, respectively) and (2) women with or without insulin resistance (polycystic ovary syndrome insulin resistance and Polycystic ovary syndrome none-insulin resistance, respectively). Serum asprosin was measured by using enenzyme-linked immunosorbent assay. RESULTS: Serum asprosin levels showed no significant difference between the polycystic ovary syndrome and control groups. However, it was significantly lower in the Polycystic ovary syndrome HA and insulin resistance groups compared with the respective Polycystic ovary syndrome none-hyperandrogenism and none-insulin resistance groups (p<0.05). In the Polycystic ovary syndrome group, serum asprosin was negatively correlated with body mass index, luteinizing hormone, testosterone, basal antral follicles, fasting insulin, homeostatic model assessment of insulin resistance, and triglycerides. After adjusting for body mass index, the correlations were not significant, and asprosin was only positively correlated with prolactin (prolactin; r=0.426, p<0.001). CONCLUSION: Our study shows that women with polycystic ovary syndrome hyperandrogenism or insulin resistance exhibit significantly lower serum asprosin levels compared with controls, and the lower asprosin level directly correlated with prolactin level.
publisher Associação Médica Brasileira
publishDate 2021
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021000500590
work_keys_str_mv AT jiangyonghui serumasprosinlevelindifferentsubtypesofpolycysticovarysyndromeacrosssectionalstudy
AT liuyue serumasprosinlevelindifferentsubtypesofpolycysticovarysyndromeacrosssectionalstudy
AT yuzhiheng serumasprosinlevelindifferentsubtypesofpolycysticovarysyndromeacrosssectionalstudy
AT yangping serumasprosinlevelindifferentsubtypesofpolycysticovarysyndromeacrosssectionalstudy
AT zhaoshigang serumasprosinlevelindifferentsubtypesofpolycysticovarysyndromeacrosssectionalstudy
_version_ 1756410118654656512